Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
08/2000
08/23/2000CN1264375A Crystal modification of N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
08/23/2000CN1264371A Pyrazine derivatives, their preparation and medicines containing them
08/23/2000CN1055687C Novel piperazine carboxamides
08/23/2000CN1055684C Method for preparing substituted pyridine
08/22/2000USRE36831 Iron-pyridone complexes for anemia
08/22/2000US6107329 Hypotensive agents; cardiovascular disorders
08/22/2000US6107315 Nervous system disorders
08/22/2000US6107309 Hemoregulatory compounds
08/22/2000US6107301 1N-alkyl-N-arylpyrimidinamines and derivatives thereof
08/22/2000US6107299 Insecticides; miticides
08/22/2000US6107298 Methods for prevention and treatment of Tourette's syndrome and schizophrenia
08/22/2000US6107066 Coumarin derivative-n-linked lipid used as a fluorophore capable of undergoing energy transfer
08/22/2000US6106908 Liquid crystalline (E, E)-butadiene compounds and mixtures and devices containing such compounds
08/17/2000WO2000047561A1 Non-nucleoside reverse transcriptase inhibitors
08/17/2000WO2000047560A2 Process for the preparation of asymmetrical 1,4-dihydro-pyridine-dicarboxylic acid esters
08/17/2000WO2000047554A2 INHIBITORS OF FACTOR Xa
08/17/2000WO2000047553A2 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
08/17/2000WO2000047210A1 Use of 4-amino pyridine for treatment of peripheral neuropathies
08/17/2000WO2000027819A3 Antrhranilic acid amides and the use thereof as medicaments
08/17/2000WO2000012076A9 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
08/17/2000CA2362375A1 Alkenyl and alkynyl compounds as inhibitors of factor xa
08/17/2000CA2362135A1 Non-nucleoside reverse transcriptase inhibitors
08/17/2000CA2361428A1 Inhibitors of factor xa
08/16/2000EP1028112A1 Phenylglycinolamides linked by a hetero-atom with antiatherosclerotic agents
08/16/2000EP1028111A1 Amide derivatives or salts thereof
08/16/2000EP1028110A1 Novel dihydronaphthalene compounds and process for producing the same
08/16/2000EP1027890A2 Homer a new target of treating psychiatric disorders
08/16/2000EP1027403A2 5-arylindane derivatives and ferroelectric liquid crystal mixture containing same
08/16/2000EP1027397A1 Electrochrome polymer systems
08/16/2000EP1027342A1 Cyclopentene derivatives useful as antagonists of the motilin receptor
08/16/2000EP1027336A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
08/16/2000EP1027335A1 Ortho-hydroxypyridinone derivatives as iron chelating and antioxidant agents
08/16/2000EP1027334A1 Substituted 2-(2'-pyridyloxy)phenyl acetamides as fungicides and pesticides
08/16/2000EP1027333A1 Thrombin inhibitors
08/16/2000EP1027328A1 Substituted anilides
08/16/2000EP0812194B1 Use of substituted pyridine compounds for treating atopic dermatitis and contact dermatitis
08/16/2000EP0805802B1 Substituted phenyl compounds as endothelin antagonists
08/16/2000EP0738259B1 Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them
08/16/2000CN1263094A Method for synthesizing 4-trifluoromethyl pyridine compound
08/16/2000CN1055469C Optically pure salts of pyridinylmethyl sulfinyl-1H-benzimidazole compounds, its preparing method and use
08/16/2000CN1055461C Aryl acetic acid derivatives and use as germicide
08/15/2000US6103946 Manufacture of α-olefins
08/15/2000US6103936 Reacting aldehyde, sulfide, sulfone, or sulfoxide with formamide in presence of acid catalyst, and optionally a dehydrating agent
08/15/2000US6103907 Phenylalkylcarboxylic acid compounds and compositions for treating hyperglycemia
08/15/2000US6103906 Process for the preparation of 2,6-pyridinedicarboxylic acid esters
08/15/2000US6103762 A biaromatic compounds in which the aromatic nuclei are connected by a propynylene or allenylene divalent radical, useful as human or veterinary medicine or used in cosmetics or keratinization disorders
08/15/2000US6103720 Ketobenzamides as calpain inhibitors
08/10/2000WO2000046203A2 G-protein coupled heptahelical receptor binding compounds and methods of use thereof
08/10/2000WO2000046187A2 Antizyme modulators and their use
08/10/2000WO2000046184A1 N2-phenylamidine derivatives
08/10/2000WO2000046179A1 Process for producing aromatic primary amine by low-pressure hydrogenation of aromatic nitrile
08/10/2000WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors
08/10/2000DE19903128A1 Production of ethylenediaminetetraacetic acid (2-aminoethyl)pyrid-2-yl disulfide, useful as a chelating agent, comprises a reaction of ethylenediaminetetracetic acid salt with pyridyldithioethanamine
08/10/2000CA2362401A1 G-protein coupled heptahelical receptor binding compounds and methods of use thereof
08/10/2000CA2362259A1 Antizyme modulators and their use
08/09/2000EP1026151A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides and insecticides
08/09/2000EP1026149A1 Amidocarboxylic acid derivatives
08/09/2000EP1025102A1 Bicyclic kinase inhibitors
08/09/2000EP1025090A1 Vitronectin receptor antagonists
08/09/2000EP1025086A1 Benzamidine derivatives as factor xa inhibitors
08/09/2000EP1025085A1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
08/09/2000EP1024814A2 Use of antifungal agents for the topical treatment of fungus-induced mucositis
08/09/2000EP1024696A1 Combination therapy for reducing the risks associated with cardio- and cerebrovascular disease
08/09/2000EP0820434B1 Phenoxyethylamine derivatives having high affinity for the 5-ht 1a receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives
08/09/2000EP0623132B1 Disubstituted polycyclic systems as cognition enhancers
08/09/2000CN1262676A 吡啶衍生物 Pyridine derivatives
08/09/2000CN1262667A Reduction of carbonyl compounds by silane in presence of zinc catalyst
08/09/2000CN1262620A Beta-Alkoxyacrylates against malaria
08/09/2000CN1262618A NF-KB inhibitors containing as active ingredient phenylmethyl benzoquinone
08/09/2000CN1262272A HIV proteinase inhibitor
08/09/2000CN1262270A Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide
08/09/2000CN1262269A Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide
08/08/2000US6100426 Anti-viral compounds
08/08/2000US6100403 Production of benzaldehyde compounds
08/08/2000US6100263 Controlling animal pests or harmful fungi; 2-methoxyimino-2-(2'-(1?-methyl,1?-(1?'-(6??-(4??'-chlorophenyl) -hexyloxyimino) ,2?',2?'-dimethylpropyl))iminooxymethyl)-phenylacetic acid monomethylamide, for example
08/08/2000US6100258 Aromatic amine compounds that antagonize the pain enhancing effects of prostaglandins
08/03/2000WO2000044740A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044731A1 Novel hydroxyamidino carboxylate derivatives useful as nitric oxide synthase inhibitors
08/03/2000WO2000044724A1 Improved method for the preparation of 3,5-dichloro-2,4,6-trifluoropyridine
08/03/2000WO2000044717A2 Synthesis of oligoketides
08/03/2000WO2000044713A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
08/03/2000WO2000044710A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044707A1 Novel substituted guanidine derivatives and process for the preparation thereof
08/03/2000WO2000044372A1 A method for treating patients with acne by administering a cyclic gmp pde inhibitor
08/03/2000WO2000003975A3 Aryl vinyl ether derivatives and their use as herbicides
08/03/2000DE19903126A1 New sulphur substituted sulphonylaminocarboxylic acid N-arylamide derivatives used for treating e.g. cardiovascular diseases and atherosclerosis
08/03/2000CA2361040A1 Synthesis of oligoketides
08/03/2000CA2356855A1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356481A1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356346A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
08/03/2000CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors
08/02/2000EP1024135A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides and insecticides
08/02/2000EP1024134A1 Aminobutanoic acid derivatives
08/02/2000EP1023316A2 Methods and compositions for lipidization of hydrophilic molecules
08/02/2000EP1023267A1 Pyridyl compounds and pharmaceutical compositions containing them
08/02/2000EP1023266A2 Process for making diaryl pyridines useful as cox-2 inhibitors
08/02/2000EP1023251A1 Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them
08/02/2000EP0527889B1 Quinolizinone type compounds
08/02/2000CN1261883A Novel compounds